Cerenis Therapeutics News

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

08.03.16	Cerenis Therapeutics Announces Its Participation to the 28th ROTH Capital Partners Annual Conference (Businesswire)
03.03.16	Cerenis Therapeutics Announces the Publication of an Initiation of Coverage Report by KEPLER CHEUVREUX, within the Framework of the Share’s Market Coverage (Businesswire)
01.03.16	Cerenis Therapeutics: 2015 Annual Results (Businesswire)
25.02.16	Cerenis Therapeutics Featured Prominently at the 25th Conference of the ASIAN PACIFIC ASSOCIATION FOR THE STUDY OF THE LIVER (APASL) (Businesswire)
25.02.16	Cerenis Therapeutics Featured Prominently at the 25th Conference of the ASIAN PACIFIC ASSOCIATION FOR THE STUDY OF THE LIVER (APASL) (Businesswire)
16.02.16	Cerenis Therapeutics: Cash Position and Revenue for 2015 (Businesswire)
26.01.16	Cerenis Therapeutics: 2016 Financial Calendar (Businesswire)
17.12.15	Cerenis Therapeutics Admitted to the SRD (Defered Settlement Service) "Long-Only” (Businesswire)
23.11.15	Cerenis’ Flagship Product Named One of 2015’S Most Promising Cardiovascular Projects at the American "Therapeutic Area Partnerships” (TAP) Conference (Businesswire)
12.11.15	Cerenis Therapeutics: Cash position and revenue for Q3 2015 (Businesswire)
10.11.15	Cerenis Therapeutics: New Data for CER-001 Presented in Key Oral Session at American Heart Association (AHA) Conference 2015 (Businesswire)
10.11.15	Cerenis Therapeutics: New Data for CER-001 Presented in Key Oral Session at American Heart Association (AHA) Conference 2015 (Businesswire)
03.11.15	CER-001: Analysis of clinical results to be presented at the American Heart Association Scientific Congress, on November 9, 2015 in Orlando, United States (Businesswire)
26.05.15	Cerenis Therapeutics Featured Prominently at the INTERNATIONAL SYMPOSIUM ON ATHEROSCLEROSIS (IAS) (Businesswire)
27.03.15	Outstanding Success of Cerenis Therapeutics’ IPO with €53.4 Million Raised on Euronext Paris (Businesswire)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Givaudan	4’040.00	1.71 %	K V
Geberit	547.80	1.59 %	K V
Part Grp Hldg	1’297.00	1.49 %	K V
ABB	51.94	1.29 %	K V
Swiss Life Hldg	691.80	1.26 %	K V
Zurich Insur Gr	548.00	-0.18 %	K V
Kuehne+Nagel Int	210.90	-0.33 %	K V
Swiss Re	128.20	-0.66 %	K V
Sonova Hldg	293.00	-0.85 %	K V
Novartis	87.94	-0.92 %	K V